Annual report pursuant to Section 13 and 15(d)

Financial Instruments

v3.25.0.1
Financial Instruments
12 Months Ended
Dec. 28, 2024
Investments, Debt and Equity Securities [Abstract]  
Financial Instruments Financial Instruments
Financial Instruments Recorded at Fair Value on a Recurring Basis
December 28, 2024 December 30, 2023
(In millions) Level 1 Level 2
Level 3
Total Level 1 Level 2 Total
Cash equivalents
Money market funds $ 1,496  $ —  $ —  $ 1,496  $ 969  $ —  $ 969 
Corporate debt securities —  806  —  806  —  753  753 
U.S. government and agency securities 130  —  —  130  1,252  —  1,252 
Non-U.S. government and agency securities —  116  —  116  —  135  135 
Time deposits and certificates of deposits —  107  —  107  —  205  205 
Short-term investments
Corporate debt securities —  814  —  814  —  506  506 
Time deposits and certificates of deposits —  10  —  10  — 
Asset-backed and mortgage-backed securities —  28  —  28  —  34  34 
U.S. government and agency securities 332  82  —  414  1,209  28  1,237 
Non-U.S. government and agency securities —  79  —  79  —  54  54 
Other non-current assets
Time deposits and certificates of deposits —  —  — 
Deferred compensation plan and other investments 197  —  25  222  133  —  133 
Total assets measured at fair value $ 2,155  $ 2,043  $ 25  $ 4,223  $ 3,563  $ 1,725  $ 5,288 
Deferred compensation plan investments are primarily mutual fund investments held in a Rabbi trust established to maintain the Company’s executive deferred compensation plan.
The following is a summary of cash equivalents and short-term investments:
December 28, 2024 December 30, 2023
Cost/ Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Cost/ Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value
(in millions) (in millions)
Asset-backed and mortgage-backed securities $ 30  $ —  $ (2) $ 28  $ 35  $ —  $ (2) $ 33 
Corporate debt securities 1,621  —  (1) 1,620  1,259  —  —  1,259 
Money market funds 1,496  —  —  1,496  969  —  —  969 
Time deposits and certificates of deposits 117  —  —  117  214  —  —  214 
U.S. government and agency securities 544  —  —  544  2,487  —  2,490 
Non-U.S. government and agency securities 195  —  —  195  189  —  —  189 
$ 4,003  $ —  $ (3) $ 4,000  $ 5,153  $ $ (2) $ 5,154 
As of December 28, 2024 and December 30, 2023, the Company did not have material available-for-sale debt securities which had been in a continuous unrealized loss position of more than twelve months.
The contractual maturities of investments classified as available-for-sale are as follows:
December 28, 2024 December 30, 2023
Amortized Cost Fair Value Amortized Cost Fair Value
(In millions) (In millions)
Due within 1 year $ 2,073  $ 2,073  $ 3,792  $ 3,792 
Due in 1 year through 5 years 406  405  361  364 
Due in 5 years and later 27  26  32  30 
$ 2,506  $ 2,504  $ 4,185  $ 4,186 
Financial Instruments Measured at Fair Value on a Non-Recurring Basis
As of December 28, 2024 and December 30, 2023, the Company had non-marketable securities in privately-held companies of $468 million and $155 million, respectively, which are recorded at estimated fair value based on Level 3 inputs.
Financial Instruments Not Recorded at Fair Value
The carrying amounts and estimated fair values of the Company’s long-term debt are as follows:
  December 28, 2024 December 30, 2023
  Carrying
Amount
Estimated
Fair Value
Carrying
Amount
Estimated
Fair Value
  (In millions) (In millions)
Current portion of long-term debt, net $ —  $ —  $ 751  $ 741 
Long-term debt, net of current portion $ 1,721  $ 1,543  $ 1,717  $ 1,630 
The estimated fair value of the Company’s long-term debt is based on Level 2 inputs of quoted prices for the Company’s debt and comparable instruments in inactive markets.
The fair value of the Company’s accounts receivable, accounts payable and other short-term obligations approximate their carrying value based on existing terms.
Hedging Transactions and Derivative Financial Instruments
Foreign Currency Forward Contracts Designated as Accounting Hedges
The Company enters into foreign currency forward contracts to hedge its exposure to foreign currency exchange rate risk related to future forecasted transactions denominated in currencies other than the U.S. Dollar. These contracts generally mature within 24 months and are designated as accounting hedges. As of December 28, 2024 and December 30, 2023, the notional value of the Company’s outstanding foreign currency forward contracts designated as cash flow hedges was $2.2 billion and $2.4 billion, respectively. The fair value of these contracts as of December 28, 2024 is recorded within Prepaid expenses and other current assets, Accrued liabilities and Other long-term liabilities of $6 million, $60 million and $11 million, respectively. As of December 30, 2023, the fair value of these contracts was recorded within Prepaid expenses and other current assets and Accrued liabilities of $24 million and $18 million, respectively.
Foreign Currency Forward Contracts Not Designated as Accounting Hedges
The Company also enters into foreign currency forward contracts to reduce the short-term effects of foreign currency fluctuations on certain receivables or payables denominated in currencies other than the U.S. Dollar. These forward contracts generally mature within 3 months and are not designated as accounting hedges. As of December 28, 2024 and December 30, 2023, the notional value of these outstanding contracts was $642 million and $568 million, respectively. The fair value of these contracts was not material as of December 28, 2024 and December 30, 2023.
The cash flows associated with derivative instruments as cash flow hedging instruments are classified in the same category within the Consolidated Statement of Cash Flows as the cash flows of the related items.